Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution During Therapy for Metastatic Breast Cancer

Science Translational Medicine
Medicine
2015English

Circulating Tumor Cells Detection in Tumor Draining Vein of Breast Cancer Patients

Scientific Reports
Multidisciplinary
2019English

Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer

Cancer Research
Cancer ResearchOncology
2017English

Change in Circulating Tumor DNA After Hepatic Resection for Metastatic Colorectal Cancer

HPB
HepatologyGastroenterology
2018English

Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients

SpringerPlus
Multidisciplinary
2015English

Circulating Tumor and Endothelial Cells as Predictors of Response in Metastatic Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2007English

Circulating Cell-Free DNA for Metastatic Cervical Cancer Detection, Genotyping and Monitoring

Clinical Cancer Research
Cancer ResearchOncology
2017English

Association Between Circulating Tumor Cells and Peripheral Blood Monocytes in Metastatic Breast Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Cell-Free Circulating DNA Integrity Is an Independent Predictor of Impending Breast Cancer Recurrence

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy